Clinical trial
A Randomized Phase III Trial of Sequential High Dose Chemotherapy or Standard Chemotherapy for Optimally Debulked FIGO Stage III and IV Ovarian Cancer
NCT00004921 is registered in ClinicalTrials.gov with EBMT Solid Tumors Working Party as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase III Trial of Sequential High Dose Chemotherapy or Standard Chemotherapy for Optimally Debulked FIGO Stage III and IV Ovarian Cancer
- Lead sponsor
- EBMT Solid Tumors Working Party
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 1998
- Completion date
- September 30, 2007
- Enrollment
- Not reported
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer